EUVIMEDEUVIMED entdecken
Editorial

Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?

Nikolaj Frost, Ludovica Mollica, Roberto Ferrara

European Journal of Cancer · 2026-06 · 240 · 116726

DOI: 10.1016/j.ejca.2026.116726 ↗

Kurz gefasst

Editorial in der Zeitschrift European Journal of Cancer, 2026-06. Verfasst von Nikolaj Frost und 2 weiteren Autor:innen. Beteiligte Einrichtung: Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Pulmonary…. Die Arbeit nennt 18 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Pulmonary Medicine, Berlin, Germany; National Center for Tumor Diseases (NCT),…
  • University Vita-Salute San Raffaele, Milan Italy; Department of Medical Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.

Zitieren

APA

Frost, N., Mollica, L., & Ferrara, R. (2026). Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?. European Journal of Cancer, 240, 116726. https://doi.org/10.1016/j.ejca.2026.116726

Vancouver

Frost N, Mollica L, Ferrara R. Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?. European Journal of Cancer. 2026;240:116726. doi:10.1016/j.ejca.2026.116726

BibTeX
@article{Frost2026,
  author = {Frost, Nikolaj and Mollica, Ludovica and Ferrara, Roberto},
  title = {Molecular bycatch in early-stage NSCLC: Keep, discard, or redefine?},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {240},
  pages = {116726},
  doi = {10.1016/j.ejca.2026.116726}
}
Kostenlos starten →